Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

What's In Store For SmileDirectClub's (SDC) Q4 Earnings?

Published 02/19/2020, 07:54 AM
Updated 07/09/2023, 06:31 AM

SmileDirectClub, Inc. (NASDAQ:SDC) is scheduled to report fourth-quarter 2019 results on Feb 25, after market close.

Despite surging operating expenses, the company is likely to have gained from a strong international presence.

SmileDirectClub delivered a positive earnings surprise of 10.1% in the last reported quarter. The average trailing four-quarter positive surprise was also the same.

Q4 Estimates Picture

For the to-be-reported quarter, the Zacks Consensus Estimate for revenues is pegged at $198.5 million. The same for adjusted earnings per share is a loss of 9 cents.

Let’s delve deeper.

Factors to Note

SmileDirectClub enjoys a strong international presence, which is likely to have aided fourth-quarter revenues.

Outside the United States, SmileDirectClub has a wide presence across Canada, Australia, the United Kingdom, New Zealand and Ireland. The company’s efforts to further expand internationally, driven by a broad array of products, are expected to reflect on results for the quarter to be reported.

SmileDirectClub, Inc. Price and EPS Surprise

SmileDirectClub, Inc. price-eps-surprise | SmileDirectClub, Inc. Quote

Management is upbeat about a series of product launches including retainers, lip balm, bright on premium whitening and an LED accelerator light. Also, last July, the company had launched the nighttime-only Clear Aligner product. Management is also optimistic about SmileDirectClub’s SmileShop rollout. These are expected to have driven its fourth-quarter revenues.

That’s not all. The company’s retail partnership agreements aided it in commercializing products. For instance, retail arrangements with CVS Health (NYSE:CVS) and Walgreens in the United States, Chemist Warehouse in Australia, and Shoppers Drug Mart in Canada deserve mention. These are expected to reflect on the to-be-reported quarter’s results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, management expects to have incurred incremental legal expenses in the fourth quarter, which might have pushed up operating costs. This is likely to have impacted margins.

Earnings Whispers

Per our proven model, a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) to deliver a positive earnings surprise. This is not the case here as you will see below.

Earnings ESP: SmileDirectClub has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: The company currently carries a Zacks Rank #4 (Sell).

Stocks Worth a Look

Here are a few medical stocks worth considering as these have the right combination of elements to post an earnings beat in the to-be-reported quarter.

Nevro Corp. (NYSE:NVRO) has an Earnings ESP of +3.45% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Tandem Diabetes (NASDAQ:TNDM) has an Earnings ESP of +86.44% and a Zacks Rank #2.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See 5 Stocks Set to Double>>



CVS Health Corporation (CVS): Free Stock Analysis Report

Nevro Corp. (NVRO): Free Stock Analysis Report

Tandem Diabetes Care, Inc. (TNDM): Free Stock Analysis Report

SmileDirectClub, Inc. (SDC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.